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Experimental Studies on
Arsenic Absorption Routes in Rats
by Tadeusz Dutkiewicz*
Pentavalent inorganic arsenic was introduced by intravenous, intratracheal, gastrointestinal, and skin
application in doses 0.1 to 4.0 mg/kg in rats. Isotopic technics were applied by use ofAs74. It was found
that the dynamics ofarsenic distribution in the body as well as the kinetics ofits elimination in urine and
feces varies very substantially, depending on the mode of administration. Intravenous administration of
As causes immediate appearance of arsenic in most tissues and a slow decrease of its concentrations in
time. Similar situations could be observed with intratracheal dosing, because arsenic is very rapidly
absorbed from the site ofadministration. Concentration intissuesincreases more slowly aftergastrointes-
tinal resorption. Skin application causes rwst the accumulation ofarsenic in the skin and next continuous,
slow transport from the skin into the blood stream.
The rate ofskin resorption was 1.14-33.1 ,ug/cm2-hr for 0.01-0.2M concentrations. The red blood cell
level of arsenic is very substantial and does not change with time, which indicates the accumulation of
arsenic in this tissue.
The elimination of arsenic occurred chiefly in urine and feces, but the urine/feces ratio changed very
substantially, depending on the route ofadministration. The kinetics ofarsenic elimination in urine was
multiphasic, being three-phase in case of intravenous and intratracheal administration and two-phase
after gavage and skin resorption. After intravenous administration of As, the half-times of elimination
were 2.5, 10, and 690 hr, respectively.
Administration of selenium salts during the slow phase increased the rate of arsenic elimination. The
straight-line relations found between the absorbed dose of arsenic and its blood or urine concentrations
could serve as baselines for exposure tests for humans.
Introduction
In industrialized regions, like upper Silesia in Po-
land, there arise many environmental toxicology
problems. One of the most important is the evalua-
tion of exposure ofhuman populations to toxic met-
als. An example is the study ofmetal content in hair
of school children in this region (1). By use of a
neutron activation method, 17 elements have been
found, among others Zn, Cd, Cu, Hg, Se, and also
arsenic, which appeared in higher concentrations in
the vicinity of zinc smelters.
Arsenic is widely distributed in nature and its
toxic properties have been known for centuries.
Sometimes arsenic occurs in the lithosphere or in the
hydrosphere in significant concentrations, and then
this deserves special attention. Such is the case in a
region in Czechoslovakia where coal containing up
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to 1530 mg/kg of arsenic compounds is used (2) or
where well water, near an arsenic mine in Poland,
has an arsenic concentration up to 0.33 mg/dm3 (3).
Burning of coal and some industrial procedures as
smelting of arsenic-containing ores, agriculture use
of arsenic fungicides and pesticides, and even
household detergents can produce contamination of
the environment with arsenic compounds.
From the Novaky power station in Czecho-
slovakia 138 tons ofarsenic enter the atmosphere in
one year (4).
In the soil, the arsenic concentrations can rise to
hundreds of milligrams per kilogram (5). The pres-
ence of arsenic compounds in soil, water, and air
leads to their intake in plants and animals, including
man. In this point there arises the question of
proper methods ofevaluation ofexposure ofhuman
populations. Both industrial and environmental ex-
posure should be considered, as well as the main
sources of absorption: air, water, and food.
In evaluation of exposure, it is most essential to
know the absorbed dose during a defined period of
August 1977 173time. This implies knowledge of uptake, distribu-
tion in the body, and elimination, taking into con-
sideration all possible routes of absorption.
Very often concentrations of metals in index
media (blood, urine) are taken as indicators ofdose.
To use the metal content in blood or urine as an
indicatorofexposure, the absorption-elimination or
absorption-concentration relationship must be
known. This implies the necessity of distribution
dynamics andeliminationkinetics studiesby various
ways of absorption.
No sufficient data were available concerning the
behavior of arsenic inorganic compounds in the
body, and for this reason the recent study was un-
dertaken. It includes the absorption kinetics of ar-
senic by blood red cells in vitro and in vivo, the
dynamics of arsenic distribution in the body, the
kinetics ofelimination ofarsenic in urine, feces, and
expired air, the distribution and elimination ofarse-
nic when administered daily, and investigation of
compounds influencing the elimination rates. Four
routes were taken into consideration; intravenous
and intratracheal administration, gastrointestinal
(gavage), and skin resorption.
The results deal only with the differences or
similarities in arsenic distribution in the body and
the kinetics ofelimination after various ways-ofab-
sorption. Administration ofselenium and its action
ontheeliminationofarsenicwillbealsoconsidered.
Methodology
The majority of experiments were performed on
white 170-200 g female, Wistar rats, fed a standard
diet. Drinking water was given ad libitum. During
the experiments the animals were kept in all-glass
metabolic Simax cages thatallowed separate collec-
tion of urine and feces samples. The samples were
taken each day.
Arsenic in the form of sodium arsenate
Na2HAsO.,
- 7 H20 was used as a carrier and
labeled with 74As. Various doses of arsenic were
used (in the range 0.1-4.0 mg/kg) but in all cases the
single dose had a volume of0.3 cm3 and an activity
of 1-2 uCi (160,000-320,000 counts/min).
In experiments ofskin resorption ofsodium arse-
nate aqueous solutions, the rats tails were im-
mersed for 1 hr in 0.01, 0.1, or 0.2M solution.
The animals were sacrificed by desanguination
under ethyl ether narcosis after 1, 2, 5, 24, 72, 120,
168, and 240 hr, and arsenic was determined in the
following organs and tissues: bowels, muscles,
bones, skin (skin of tails separately in skin resorp-
tion), liver, kidneys, lungs, spleen, heart, blood,
and hair. The samples offeces, bowels, skin, mus-
cles, and bones were homogenized, blood and urine
were diluted with water, the remaining organs and
tissues were digested by the use of sulfuric and ni-
tric acid.
The content of arsenic was calculated by com-
parison ofthe measured activity ofthe sample with
the activity of a standard solution.
Results and Discussion
The results presented actually in this paper are
limited to those which illustrate the differences or
similarities in various routes of application (6).
Arsenic content in various organs after intraven-
ous application is given in Table 1. The higher con-
centrations were obtained in liver, kidneys, lung,
spleen, and blood. Thefigures inTable 1 were used
as reference for a comparison of the dynamics of
arsenic distribution by other routes of absorption.
Taking into consideration the distribution of ar-
senic in various tissues, we can observe the influ-
ence ofthe absorption route. Ingeneral, the content
of arsenic in tissues is similar for the intravenous
and intratracheal administration on the one hand
and gastrointestinal and skin resorption on the
other. The content ofarsenic in tissues after 24 hr is
less than 20% ofthe applied dose. The only excep-
Table 1. Dynamics of arsenic distribution after intravenous administration 1 mg/kg doses ofNa2HAsO4 in rats.
Tissue Percentage ofthe dose/g tissue various times after administration
ororgan I hr 2 hr 5 hr 24 hr 120 hr 240 hr
Intestines 0.15 0.14 0.072 0.035 0.092 0.055
Muscle and bones 0.13 0.10 0.066 0.053 0.055 0.051
Skin 0.20 0.10 0.039 0.044 0.053 0.038
Liver 3.85 3.73 3.47 2.75 2.17 1.73
Kidney 2.09 1.49 0.41 0.32 0.46 0.53
Spleen 1.60 1.96 2.15 1.72 1.90 1.70
Lung 2.72 2.47 2.49 2.00 1.85 1.09
Heart 0.47 0.32 0.23 0.28 0.40 0.30
Blood 1.49 2.16 2.78 2.73 3.95 3.76
Tail 0.83 0.79 0.73 0.64 0.24 0.17
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is present outside blood, due to its deposit at the
site ofapplication. The results in Table 2 and 3 give
the dynamics of arsenic distribution in liver and
spleen is shown.
The dynamics of arsenic liver content is similar
for intravenous and intratracheal administration but
varies very much with skin resorption (Fig. 1). The
first detected amounts, after 24 hr, are very small,
but they increase in time. This is due to the rela-
tively slow transport of arsenic from the site of ap-
plication (the skin of the tail). The situation is simi-
lar if we consider the arsenic content of spleen.
Here again we observe slower increases of arsenic
Table 2. Dynamics of arsenic distribution in liver with various
routes of administration to rats.
Percentage ofdose/g tissue at various times
Route of after administration
administration I hr 2 hr 5 hr 24 hr 120 hr 240 hr
Intravenous 3.85 3.73 3.47 2.75 2.17 1.73
Intratracheal 2.49 2.59 3.25 3.08 1.69 1.02
Gastrointestinal 0.34 0.27 0.32 0.26 0.19 0.37
Skin resorption 0.066 0.36 0.28
Table 3. Dynamics of arsenic distribution in spleen with various
routes ofadministration to rats.
Percentage ofdose/g tissue at various times
Route of after administration
administration 1 hr 2 hr 5 hr 24 hr 120 hr 240 hr
Intravenous 1.60 1.96 2.15 1.72 1.90 1.70
Intratracheal 0.71 1.07 1.55 1.69 2.48 2.75
Gastrointestinal 0.19 0.40 0.65 1.07 0.78 1.20
Skin resorption - - 0.29 0.63 0.96
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FIGURE 1. Absorption ofarsenic in red cells in vitro and in vivo
with administration by various routes: (x) in vitro; (A) intra-
tracheal; (o) skin resorption; (o) intravenous; (A) gastrointes-
tinal.
concentrations after skin or gastrointestinal ad-
ministration in comparison with the intravenous
route.
Skin resorption first causes accumulation of ar-
senic in the skin and next slow, but continuous
transport into the blood stream and to othertissues.
Skin resorption ofarsenic from aqueous solutions
of its salts was very substantial and for 0.01-0.2M
concentrations was as much as 1.14-33.1
gg/cm2-hr. Simple calculations considering 700 cm2
to be the surface area ofboth hands show that skin
resorption amounts to 0.8 to 23.2 mg/hr, which is
considerably more than by absorption by the res-
piratory track in industrial conditions.
Arsenic is eliminated from the body in various
ways: urine, feces, milk, respiratory tract, and skin.
The largest amounts are eliminated in urine and
feces. Elimination by the respiratory tract was neg-
ligible, amounting to 0.053-0.35% of the applied
dose. In the same period oftime the elimination by
urine and feces was very substantial, as shown in
Table 4.
Table 4. Elimination ofarsenic in urine and feces at 10 days after
various routes ofadministration.
Route of Elimination of the absorbed dose, %
administration Urine Feces
Intravenous 39 5
Intratracheal 35 15
Gastrointestinal 20 30
Skin 30 30
The elimination followed three-phase kinetics
after intravenous and intratracheal application and
a two-phase after gastrointestinal and skin resorp-
tion. The half-time of elimination was 2.5 hr in the
first, about 10 hr in the second, and about 690 hr in
the third phase. With skin resorption the half-time
ofelimination in urine was 28 hr in the first (second)
and 240 hr in the second (third) phase. We can as-
sume that after skin resorption the first phase does
not exist.
On administration ofrepeated doses, the elimina-
tion in urine reaches a constant percentage of the
absorbed daily dose. This is very important for the
calculation of the absorbed amounts of arsenic.
The application oftrivalent arsenicgives substan-
tially the same results.
Figures 2 and 3 show arsenic elimination in urine
and in feces. As to illustrate the most important
differences, skin resorption and intravenous ad-
ministration of the same applied dose were
selected. The lines on the graphs indicate that pro-
cesses of elimination of arsenic by both urine and
feces are multiphase. The urine/feces elimination
ratio changes with the route of administration,
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FIGURE 2. Elimination of arsenic in urine: (e) intravenous ad-
ministration, dose 200 ,ug As, 38.53% ofdose elirninated; (o)
skin resorption, dose 203 ,ig As (by immersion in O.iM
solution), 30.39% of dose eliminated.
which is not unique for arsenic and can be demon-
strated for many other metals (Table 5).
The data in Table 5 (6) show that the urine/feces
ratio of elimination of various metals varies very
much for different routes of administration, which
is very unfortunate for the purpose of developing
integral exposure tests. Those tests are based
mostly on determination of metals in urine. The
concentrations of metals in urine are dependent on
the mode ofabsorption, which is usually not known
in either industrial or environmental conditions.
This is a very strong obstacle to development of
exposure tests, which are limited to only one route
of absorption.
FIGuRE 3. Elimination of arsenic in feces: (e) intravenous ad-
ministration, dose 200 ,ug, 4.86% ofdose eliminated; (o) skin
resorption, dose 203 jug As (by immersion in 0.IM solution),
29.64% of dose eliminated.
Table 5. Urine/feces ratio of elimination of various metals admis-
tered intravenously, and by skin application.
Route of Urine/feces
Element administration ratio
As Intravenous 8: 1
Skin 1:1
Be Intravenous 3 2
Skin 1: 9
Cr Intravenous 1 1
Skin 3 7
Hg Intravenous 4: 3
Skin 2: 5
Se Intravenous 4: 1
Skin 2: 1
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176Arsenic-Selenium Interaction
Many possible accelerators ofarsenic elimination
were investigated; among others selenium am-
moniate was applied in single daily dose 0.2 mg/kg
during the slow phase of arsenic elimination.
The selection of selenium salts was done on the
basis of previous experiments by Dutkiewicz and
Balcerska (7) in which selenium elimination in urine
was accelerated after administration of arsenic
salts. The rate of elimination was about 12% in the
slow phase, in comparison with about 5% in the
control group. Sodium arsenate was applied 2 times
daily in single doses, 0.2 mg/kg, beginning from the
third day of experiment. The most effective of the
applied agents was glutathione, which gave an im-
provement in elimination of about 17%.
The application of selenium as an accelerating
agent caused a 20%-30% increase in the elimination
ofarsenic in urine in the slow phase, the most effec-
tive agents being unithiol, penicylamine, meth-
ionine, and cysteine, giving about 100% increase in
elimination.
Conclusions
Independent ofthe route ofadministration in vivo
or in experiments in vitro considerable amounts of
arsenic are bound to red blood cells.
The concentration of arsenic in blood is propor-
tional to th'% absorbed dose in the range 0.1-4 mg
As/kg.
The amounts of arsenic elimination in urine are
considerable. The concentrations in urine are corre-
lated with the absorbed dose.
Daily administration of the same dose leads to a
constant level of arsenic elimination in urine.
The found relations could serve as baselines for
the development ofexposure indicators in humans.
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